UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms

Medicinal research reviews, 2017-01, Vol.37 (1), p.52-97

2017

Volltextzugriff (PDF)

Active intestinal drug absorption and the solubility-permeability interplay

International journal of pharmaceutics, 2018-02, Vol.537 (1-2), p.84-93

2018

Volltextzugriff (PDF)

Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies

Drug delivery and translational research, 2020-04, Vol.10 (2), p.354-367

2020

Volltextzugriff (PDF)

Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations

PloS one, 2013-07, Vol.8 (7), p.e68237-e68237

2013

Volltextzugriff (PDF)

The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

Advanced drug delivery reviews, 2016-06, Vol.101, p.99-107

2016

Volltextzugriff (PDF)

Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products

Pharmaceutics, 2020-10, Vol.12 (11), p.1031

2020

Volltextzugriff (PDF)

Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3248

2020

Volltextzugriff (PDF)

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation

International journal of molecular sciences, 2020-05, Vol.21 (10), p.3621

2020

Volltextzugriff (PDF)

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

The AAPS journal, 2009-12, Vol.11 (4), p.740-746

2009

Volltextzugriff (PDF)

The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats

European journal of pharmaceutics and biopharmaceutics, 2007-08, Vol.67 (1), p.96-105

2007

Volltextzugriff (PDF)

A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Molecular pharmaceutics, 2012-07, Vol.9 (7), p.2009-2016

2012

Volltextzugriff (PDF)

Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study

Pharmaceuticals (Basel, Switzerland), 2024-04, Vol.17 (4), p.507

2024

Volltextzugriff (PDF)

Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability

Pharmaceutics, 2023-10, Vol.15 (10), p.2518

2023

Volltextzugriff (PDF)

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting

American journal of physiology: Gastrointestinal and liver physiology, 2009-08, Vol.297 (2), p.G371-G377

2009

Volltextzugriff (PDF)

Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs

Molecular pharmaceutics, 2009-02, Vol.6 (1), p.19-28

2009

Volltextzugriff (PDF)

The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone

Journal of pharmaceutical sciences, 2010-06, Vol.99 (6), p.2739-2749

2010

Volltextzugriff (PDF)

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide

Pharmaceutics, 2020-12, Vol.12 (12), p.1175

2020

Volltextzugriff (PDF)

The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass

Pharmaceutics, 2023-12, Vol.15 (12), p.2795

2023

Volltextzugriff (PDF)

Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein

Pharmaceutical research, 2009-04, Vol.26 (4), p.883-892

2009

Volltextzugriff (PDF)

Modern prodrug design for targeted oral drug delivery

Molecules (Basel, Switzerland), 2014-10, Vol.19 (10), p.16489-16505

2014

Volltextzugriff (PDF)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Nature communications, 2022-06, Vol.13 (1), p.3226-15, Article 3226

2022

Volltextzugriff (PDF)

Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation

International journal of molecular sciences, 2022-02, Vol.23 (5), p.2673

2022

Volltextzugriff (PDF)

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Molecular pharmaceutics, 2011-10, Vol.8 (5), p.1848-1856

2011

Volltextzugriff (PDF)

Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine

Drug metabolism and disposition, 2009-10, Vol.37 (10), p.2028-2036

2009

Volltextzugriff (PDF)

Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation

Pharmaceutics, 2021-02, Vol.13 (2), p.272

2021

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Englisch
(152)
Hebräisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms

Active intestinal drug absorption and the solubility-permeability interplay

Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies

Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations

The solubility–permeability interplay and oral drug formulation design: Two heads are better than one

Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products

Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats

A Win–Win Solution in Oral Delivery of Lipophilic Drugs: Supersaturation via Amorphous Solid Dispersions Increases Apparent Solubility without Sacrifice of Intestinal Membrane Permeability

Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study

Towards Effective Antiviral Oral Therapy: Development of a Novel Self-Double Emulsifying Drug Delivery System for Improved Zanamivir Intestinal Permeability

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting

Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs

The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide

The Complexity of Bariatric Patient's Pharmacotherapy: Sildenafil Biopharmaceutics and Pharmacokinetics before vs. after Gastric Sleeve/Bypass

Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein

Modern prodrug design for targeted oral drug delivery

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine

Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation

Suchergebnisse filtern